.Amgen has actually discussed (PDF) the first stage 3 information on its own $400 thousand chronic e...
.Biogen and also UCB's bet one's bottom dollar improving into stage 3 on the back of a failed resear...
.Italian biotech Aptadir Rehabs has actually released along with the promise that its own pipeline o...
.Surge Life Sciences has satisfied its own target in a Duchenne muscular dystrophy (DMD) study, plac...
.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, takin...
.Achilles Rehabs has actually wrecked its own approach. The English biotech is knocking off on its c...
.Aligos Rehabs is actually declaring a midstage succeed in metabolic-dysfunction affiliated steatohe...
.Basilea Pharmaceutica's job developing brand new antifungals has actually obtained a considerable i...
.Having already gathered up the USA civil rights to Capricor Rehabs' late-stage Duchenne muscle dyst...
.After dismissing the choice date for Applied Therapies' metabolic problem medication govorestat, th...